Loading…
Clinical Quality Oversight has ended
avatar for Michele Weitz

Michele Weitz

CLOVIS ONCOLOGY
Senior Director, Clinical Standards and Innovation
A pragmatist on a mission to make clinical trial regulatory requirements meaningful and accessible to a tough crowd, Michele has worked as both an employee and consultant at pharmaceutical companies of all sizes—from 23 to 111,000 employees, in many therapeutic areas and around the world during her years in clinical development, training, auditing., and operational excellence. She has developed training and presented for Fierce Life Sciences (formerly ExL), SQA, ACRP, Advanstar|CBI, Barnett International, the Multidisciplinary Association of Psychedelic Studies (MAPS), the Institute for International Research, Arena International, and the Global Strategic Management Institute (GSMI).

As Senior Director of Clinical Operations Standards and Innovation (formerly GCP Compliance Operations) at Clovis Oncology, Inc., a company committed to improving the lives of people living with cancer, Michele and her team build ethics and quality into everyday clinical trial operations through developing and executing inspection preparation and participation strategies, advising on GCP compliance issues, responding to audit and inspection findings, developing SOPs and Best Practices, designing and delivering training programs, performing investigations and risk assessments, and managing the TMF system—always with an eye toward how the regulatory requirements came to exist and why they matter to the people who must comply with them.
  • Timezone
  • Filter By Date Clinical Quality Oversight Sep 27 -29, 2021
  • Filter By Type
  • General Session - Live Streamed to Virtual Audience
  • Interactive Workshop - In-Person Only
  • Networking!
  • Track A - In-Person Only
  • Track B - In-Person Only